Search

Molly D Smithgall

from Seattle, WA
Age ~64
Get Report
Also known as:
Molly Dee Smit, Moloy Smithgall
Phone and address:
7217 28Th Ave NE, Seattle, WA 98115
(206) 525-0597
Related to:
Betty SmithgallMichael Erickson, 73Todd Smithgall, 70
Connected to:
Bruce A Smithgall, 59Carol B Smithgall, 67Charlene E Smithgall, 85Carter L Smithhart, 45David Smithhart, 58Hayley C Smithhart, 43Robert T Smithhart, 44Tatiana P Smithhart, 46Tyler M Smithhart, 41Frank Smithhisler, 79

Molly Smithgall Phones & Addresses

  • 7217 28Th Ave NE, Seattle, WA 98115 (206) 525-0597
  • Lancaster, PA
  • 7217 28Th Ave NE, Seattle, WA 98115

Work

Position: Production Occupations

Emails

m***[email protected]

Resumes

Resumes

Molly Smithgall Photo 1

Molly Smithgall

View page
Location:
Seattle, WA
Industry:
Biotechnology
Work:
Amgen 2004 - 2014
Senior Research Associate
Corixa Corporation 1999 - 2003
Senior Research Associate
Cytokine Networks 1997 - 1998
Senior Research Associate
Bristol-Myers Squibb 1989 - 1997
Senior Research Associate
Education:
Edmonds Community College 2014 - 2019
Edmonds Community College 2016 - 2017
Shippensburg University of Pennsylvania
Bachelors, Biology
Skills:
Scientist
Human Immune Cell Based Assays
Flow Cytometry
Cytokine Biology
Molecular Profiling
Ex Vivo Human Tissue Culture
Pre Clinical Therapeutic Drug Discovery and Development
Antibodies
Biomarkers
In Vitro
Assay Development
Biotechnology
Cell
Drug Development
Inflammation
Biology
Cell Biology
Life Sciences
Molly Smithgall Photo 2

Molly Smithgall

View page
Location:
Seattle, WA
Molly Smithgall Photo 3

Sr. Associate Scientist At Amgen

View page
Position:
Sr. Associate Scientist at Amgen
Location:
Greater Seattle Area
Industry:
Biotecnologie
Work:
Amgen
Sr. Associate Scientist

Publications

Us Patents

Compositions And Methods For Wt1 Specific Immunotherapy

View page
US Patent:
20030072767, Apr 17, 2003
Filed:
Aug 24, 2001
Appl. No.:
09/938864
Inventors:
Alexander Gaiger - Seattle WA, US
Patricia McNeill - Federal Way WA, US
Molly Smithgall - Seattle WA, US
Gus Moulton - Seattle WA, US
Thomas Vedvick - Federal Way WA, US
Paul Sleath - Seattle WA, US
Sally Mossman - Seattle WA, US
Lawrence Evans - Seattle WA, US
A. Spies - Shoreline WA, US
Jeremy Boydston - Seattle WA, US
International Classification:
A61K039/00
C07H021/04
C12N009/64
C12P021/02
C12N005/06
US Classification:
424/185100, 435/069100, 435/226000, 435/320100, 435/325000, 536/023200
Abstract:
Compositions and methods for the therapy of malignant diseases, such as leukemia and cancer, are disclosed. The compositions comprise one or more of a WT1 polynucleotide, a WT1 polypeptide, an antigen-presenting cell presenting a WT1 polypeptide, an antibody that specifically binds to a WT1 polypeptide; or a T cell that specifically reacts with a WT1 polypeptide. Such compositions may be used, for example, for the prevention and treatment of metastatic diseases.

Compositions And Methods For Wt1 Specific Immunotherapy

View page
US Patent:
20030082196, May 1, 2003
Filed:
Feb 15, 2001
Appl. No.:
09/785019
Inventors:
Alexander Gaiger - Seattle WA, US
Martin Cheever - Mercer Island WA, US
Patricia McNeill - Federal Way WA, US
Molly Smithgall - Seattle WA, US
Gus Moulton - Seattle WA, US
Thomas Vedvick - Federal Way WA, US
Paul Sleath - Seattle WA, US
International Classification:
A61K039/00
C07K014/435
C07K016/34
US Classification:
424/185100, 530/350000, 530/388100
Abstract:
Compositions and methods for the therapy of malignant diseases, such as leukemia and cancer, are disclosed. The compositions comprise one or more of a WT1 polynucleotide, a WT1 polypeptide, an antigen-presenting cell presenting a WT1 polypeptide, an antibody that specifically binds to a WT1 polypeptide; or a T cell that specifically reacts with a WT1 polypeptide. Such compositions may be used, for example, for the prevention and treatment of metastatic diseases.

Compositions And Methods For Wt1 Specific Immunotherapy

View page
US Patent:
20030095971, May 22, 2003
Filed:
Oct 30, 2001
Appl. No.:
10/002603
Inventors:
Alexander Gaiger - Seattle WA, US
Patricia McNeill - Federal Way WA, US
Molly Smithgall - Seattle WA, US
Gus Moulton - Seattle WA, US
Thomas Vedvick - Federal Way WA, US
Paul Sleath - Seattle WA, US
Sally Mossman - Seattle WA, US
Lawrence Evans - Seattle WA, US
A. Spies - Shoreline WA, US
Jeremy Boydston - Seattle WA, US
Assignee:
Corixa Corporation - Seattle WA
International Classification:
A61K048/00
A61K039/395
A61K039/00
C12N009/00
C12P021/02
C12N005/06
US Classification:
424/155100, 424/093210, 536/023200, 435/183000, 435/325000, 435/320100, 435/069100
Abstract:
Compositions and methods for the therapy of malignant diseases, such as leukemia and cancer, are disclosed. The compositions comprise one or more of a WT1 polynucleotide, a WT1 polypeptide, an antigen-presenting cell presenting a WT1 polypeptide, an antibody that specifically binds to a WT1 polypeptide; or a T cell that specifically reacts with a WT1 polypeptide. Such compositions may be used, for example, for the prevention and treatment of metastatic diseases.

Compositions And Methods For Wt1 Specific Immunotherapy

View page
US Patent:
20030198622, Oct 23, 2003
Filed:
Jul 12, 2002
Appl. No.:
10/195835
Inventors:
Alexander Gaiger - Seattle WA, US
Molly Smithgall - Seattle WA, US
Darrick Carter - Seattle WA, US
Martin Cheever - Mercer Island WA, US
Patricia McNeill - Federal Way WA, US
R. Sutherland - Bothell WA, US
Sally Mossman - Seattle WA, US
Lawrence Evans - Seattle WA, US
Ryan Swanson - Seattle WA, US
Assignee:
Corixa Corporation - Seattle WA
International Classification:
A61K048/00
A61K039/00
C07K014/47
C12N005/08
US Classification:
424/093200, 514/044000, 424/185100, 530/350000, 435/372000
Abstract:
Compositions and methods for the therapy of malignant diseases, such as leukemia and cancer, are disclosed. The compositions comprise one or more of a WT1 polynucleotide, a WT1 polypeptide, an antigen-presenting cell presenting a WT1 polypeptide, an antibody that specifically binds to a WT1 polypeptide; or a T cell that specifically reacts with a WT1 polypeptide. Such compositions may be used, for example, for the prevention and treatment of metastatic diseases.

Compositions And Methods For Wt1 Specific Immunotherapy

View page
US Patent:
20040126362, Jul 1, 2004
Filed:
Aug 26, 2003
Appl. No.:
10/648780
Inventors:
Alexander Gaiger - Seattle WA, US
Molly Smithgall - Seattle WA, US
Darrick Carter - Seattle WA, US
Martin Cheever - Mercer Island WA, US
Patricia McNeill - Federal Way WA, US
R. Sutherland - Bothell WA, US
Sally Mossman - Seattle WA, US
Lawrence Evans - Seattle WA, US
Ryan Swanson - Seattle WA, US
Assignee:
Corixa Corporation - Seattle WA
International Classification:
A61K048/00
US Classification:
424/093200, 514/012000, 514/044000
Abstract:
Compositions and methods for the therapy of malignant diseases, such as leukemia and cancer, are disclosed. The compositions comprise one or more of a WT1 polynucleotide, a WT1 polypeptide, an antigen-presenting cell presenting a WT1 polypeptide, an antibody that specifically binds to a WT1 polypeptide; or a T cell that specifically reacts with a WT1 polypeptide. Such compositions may be used, for example, for the prevention and treatment of metastatic diseases.

Compositions And Methods For Wt1 Specific Immunotherapy

View page
US Patent:
20030039635, Feb 27, 2003
Filed:
Apr 16, 2002
Appl. No.:
10/125635
Inventors:
Alexander Gaiger - Seattle WA, US
Molly Smithgall - Seattle WA, US
Darrick Carter - Seattle WA, US
Martin Cheever - Mercer Island WA, US
Patricia McNeill - Federal Way WA, US
R. Sutherland - Bothell WA, US
Assignee:
Corixa Corporation - Seattle WA
International Classification:
A61K048/00
C12N015/861
C12N015/86
US Classification:
424/093200, 514/044000, 435/456000
Abstract:
Compositions and methods for the therapy of malignant diseases, such as leukemia and cancer, are disclosed. The compositions comprise one or more of a WT1 polynucleotide, a WT1 polypeptide, an antigen-presenting cell presenting a WT1 polypeptide, an antibody that specifically binds to a WT1 polypeptide; or a T cell that specifically reacts with a WT1 polypeptide. Such compositions may be used, for example, for the prevention and treatment of metastatic diseases.
Control profile
Molly D Smithgall from Seattle, WA, age ~64 Get Report